Surprisingly, although osteoblastic cell fate depending on WNT10B expression appeared not to be altered, we observed a strong reduction of the adipogenic cell fate inhibitor DLK1 in MDS and AML BMSC samples on both gene and protein expression level. The gene discussed is WNT10B; the disease is myelodysplastic syndrome.